Mylan’s Perrigo May Bring Teva Into Bidding War

Analysts speculate that Israeli company may target Mylan or Perrigo.

comments Print
Mylan’s surprise bid last week for Perrigo may be just the first salvo in what could turn into a lengthy and protracted merger and acquisition fight among generic drug makers, including Teva Pharmaceuticals.